Pharma Development
Clinical Manufacturing
cGMP manufacturing through phase I, II & III
Direct API fill into capsules (using Xcelodose 600)
Dosage form preparation and blinding
Open and blinded clinical packaging and labeling
Semi-automated and fully automated overencapsulation
Wet and dry granulation
Tableting
Coating: beads and tablets
Encapsulation for powders, granules, tablets and mixed combinations
Schedule II - V control drug manufacturing
